UBS Group AG - ABVC BIOPHARMA INC ownership

ABVC BIOPHARMA INC's ticker is ABVC and the CUSIP is 00091F106. A total of 6 filers reported holding ABVC BIOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ABVC BIOPHARMA INC
ValueSharesWeighting
Q4 2022$2,693
-10.2%
4,275
+235.6%
0.00%
Q1 2022$3,000
-88.5%
1,274
-83.4%
0.00%
Q4 2021$26,0007,6600.00%
Other shareholders
ABVC BIOPHARMA INC shareholders Q2 2022
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 1,092,745$1,158,0000.02%
VANGUARD GROUP INC 375,142$398,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 49,915$52,0000.00%
BlackRock Inc. 39,042$41,0000.00%
Tower Research Capital LLC (TRC) 5,997$6,0000.00%
View complete list of ABVC BIOPHARMA INC shareholders